Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian ...